Skip to main content
Drug Story

On patent medicines (with Tim Harford)

38 min episode · 2 min read
·
Tim Harford

Episode

38 min

Read time

2 min

Topics

Productivity, Health & Wellness, Marketing

AI-Generated Summary

Key Takeaways

  • Quackery economics: Between 1810 and 1939, inflation-adjusted spending on unproven patent medicines grew 20 times faster than the US economy as a whole. Recognizing this pattern helps explain why alternative remedies persist today — they fill gaps left by expensive, inaccessible, or ineffective mainstream medicine, not simply because consumers are gullible.
  • Placebo mechanics and alcohol: Lydia Pinkham's Vegetable Compound was 20% alcohol — equivalent in strength to port or sherry. Many patent medicines also contained opium or chili, producing measurable physiological effects. Understanding this explains why users reported genuine relief: the compound delivered a real pharmacological response, just not the one advertised on the label.
  • Trust deficit drives alternative medicine: Nineteenth-century doctors routinely prescribed calomel, a mercury compound causing gum inflammation, gray skin, and jaw decay. Physicians also spread infection during childbirth while dismissing evidence of harm. When mainstream medicine is dangerous and dismissive, patients rationally seek alternatives — a dynamic that applies directly to modern vaccine hesitancy and wellness industry growth.
  • Viagra and research bias: A 2013 study found sildenafil — originally tested in 1889 exclusively on men for angina — may provide four consecutive hours of total pain relief for severe dysmenorrhea. The trial lost funding and was never scaled. Women's health conditions remain chronically underfunded, meaning treatments discovered incidentally in male-focused trials go uninvestigated for female applications.
  • Marketing over efficacy: The Pinkham business scaled by spending heavily on newspaper front-page advertising featuring Lydia's portrait, not by proving clinical results. A single $60 Boston Herald ad emptied their entire stock within two days. This demonstrates that perceived trustworthiness and emotional resonance — not evidence — drive health product adoption, a pattern visible in modern supplement marketing.

What It Covers

Tim Harford traces the rise of Lydia Pinkham's Vegetable Compound, a 20% alcohol herbal tonic marketed to women in the 1870s-1900s, examining why unproven patent medicines dominated American healthcare, how demand grew 20 times faster than the economy, and how public outrage eventually created the FDA.

Key Questions Answered

  • Quackery economics: Between 1810 and 1939, inflation-adjusted spending on unproven patent medicines grew 20 times faster than the US economy as a whole. Recognizing this pattern helps explain why alternative remedies persist today — they fill gaps left by expensive, inaccessible, or ineffective mainstream medicine, not simply because consumers are gullible.
  • Placebo mechanics and alcohol: Lydia Pinkham's Vegetable Compound was 20% alcohol — equivalent in strength to port or sherry. Many patent medicines also contained opium or chili, producing measurable physiological effects. Understanding this explains why users reported genuine relief: the compound delivered a real pharmacological response, just not the one advertised on the label.
  • Trust deficit drives alternative medicine: Nineteenth-century doctors routinely prescribed calomel, a mercury compound causing gum inflammation, gray skin, and jaw decay. Physicians also spread infection during childbirth while dismissing evidence of harm. When mainstream medicine is dangerous and dismissive, patients rationally seek alternatives — a dynamic that applies directly to modern vaccine hesitancy and wellness industry growth.
  • Viagra and research bias: A 2013 study found sildenafil — originally tested in 1889 exclusively on men for angina — may provide four consecutive hours of total pain relief for severe dysmenorrhea. The trial lost funding and was never scaled. Women's health conditions remain chronically underfunded, meaning treatments discovered incidentally in male-focused trials go uninvestigated for female applications.
  • Marketing over efficacy: The Pinkham business scaled by spending heavily on newspaper front-page advertising featuring Lydia's portrait, not by proving clinical results. A single $60 Boston Herald ad emptied their entire stock within two days. This demonstrates that perceived trustworthiness and emotional resonance — not evidence — drive health product adoption, a pattern visible in modern supplement marketing.

Notable Moment

The Pinkham company continued running advertisements urging women to write to Lydia Pinkham for personal health advice for years after her death. When exposed, the family defended the practice by claiming the "Mrs. Pinkham" referenced was actually a daughter-in-law — and insisted the public already understood this.

Know someone who'd find this useful?

Episode Transcript

This is Drug Story. I'm Thomas Getz. Today, we're sharing an episode of one of my favorite podcasts, Cautionary Tales, by Tim Harford. Tim is just super good at explaining complicated things, economics, history, and in this episode, medicine. This show is about Lydia Pinkham's vegetable compound, one of the most popular patent medicines of the late nineteenth century. Missus Pinkham's compound was sold as a women's tonic, ideal for menopause or menstrual pain and, and I'm quoting here, for all those painful complaints and weaknesses so common to our best female population. It cures bloating, headaches, nervous prostration, general debility, sleeplessness, depression, and indigestion. But did it really? No. No. It did not. Lydia Pinkham's compound was the epitome of a cure all that cured nothing. It was a secret concoction of herbs and roots and other ambiguous ingredients that promised tremendous benefits without any evidence whatsoever. Eventually, it was outrage over patent medicines like missus Pinkham's that turned into the creation of the FDA and the evidence based medicine we enjoy today. I will let Tim tell the whole story, but it's a lovely episode. And just a note before I hand off the mic, I want to thank you all truly for listening to this podcast. In just a couple of months, Drug Story has found a large and enthusiastic audience for which I am just tremendously grateful. In fact, we are hard at work wrapping up two bonus episodes for this season, including next week's show on a true miracle drug, ivermectin. That story actually picks up on many ideas that Tim explores in this episode. It is quite the tale, so expect that next week. Thank you for listening. Enjoy the show. A fearful tragedy, declared the newspaper, all caps of course. It was after all the eighteen eighties. A fearful tragedy. A clergyman of Stanford, Connecticut killed by his own wife. But why? What were the circumstances? Could the tragedy have been prevented? Never fear, the full explanation is forthcoming, but be warned. This is not actually a news report, it's an advertisement. Apparently, based on a true story. A fearful tragedy. A clergyman of Stratford, Connecticut killed by his own wife. Insanity brought on by sixteen years of suffering with female complaints the cause. Lydia E Pinkham's vegetable compound, the sure cure for these complaints would have prevented the direful deed. Well, well, it's quite a tale and quite a claim. Gather round ladies and gentlemen and take a comfortable seat, For I'm about to tell you a tale of direful deeds a plenty and of female complaints and of the most efficacious vegetable compounds you could wish for. I'm Tim Harford, and you're listening to cautionary tales. Lydia Estes Pinkham was born Lydia Estes in the city of Lynn, Massachusetts in 1819, the tenth child of a modestly wealthy family of Quakers. If you'd met Lydia as a young woman, you wouldn't have imagined that she'd get into the business of herbal …

Get the full transcript (5,069 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all Drug Story transcripts →

You just read a 3-minute summary of a 35-minute episode.

Get Drug Story summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from Drug Story

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Health Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Drug Story.

Every Monday, we deliver AI summaries of the latest episodes from Drug Story and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime